Lambert-Eaton myasthenic syndrome

Dr Hamish Smith and Dr Henry Knipe et al.

Lambert-Eaton myasthenic syndrome (LEMS) is a rare neuromuscular junction disorder of paraneoplastic or primary autoimmune etiology.

LEMS is the second most common neuromuscular junction disease after myasthenia gravis

Two-thirds of LEMS present as a paraneoplastic syndrome secondary to malignancy, most commonly lung cancer, less commonly breast, ovarian and pancreatic cancer and lymphoma.

The most common clinical feature is progressive proximal leg weakness. Deep tendon reflexes are almost always decreased. A less prominent but characteristic feature is autonomic dysfunction, most commonly dry mouth. Less common features include oropharyngeal and ocular symptoms related to weakness, such as dysphagia, dysarthria, ptosis, and diplopia.

The diagnosis is confirmed by electrodiagnostic studies and serology. Specifically, repetitive nerve stimulation demonstrates an increase in compound muscle action potential after increasing the stimulation frequency or after exercise, a phenomenon known as postactivation facilitation. Antibodies against the P/Q-type voltage-gated calcium channel are relatively specific for the diagnosis.

A diagnosis of LEMS should prompt a search for an underlying malignancy, at least including chest CT, with additional consideration of FDG-PET 4,5. These studies most commonly reveal a tumor corresponding to small cell lung carcinoma.

Share article

Article information

rID: 32427
Section: Syndromes
Synonyms or Alternate Spellings:
  • Lambert Eaton syndrome
  • Lambert-Eaton myasthenic syndrome (LEMS)
  • Lambert–Eaton syndrome
  • Lambert-Eaton myasthenia syndrome (LEMS)
  • Eaton-Lambert syndrome
  • Eaton-Lambert myasthenia syndrome

Support Radiopaedia and see fewer ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.